Agreement signedPublished 5 Jun 2023
Astellas /
Iveric
Astellas to acquire IVERIC bio for cash consideration
- Price per share
- $40.00/share
- Stage
- Agreement signed




01 / BuyerAstellas
02 / TargetIveric
What happened
Astellas agreed to pay $40.00 per share in cash for IVERIC bio, Inc. The merger agreement provides that IVERIC will become a wholly owned subsidiary of Parent.
The source
Everything on this page comes from the source below.
01
Source · Original source
Astellas to acquire IVERIC bio for cash consideration
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly